Fore Biotherapeutics

Fore Biotherapeutics is a virtual precision oncology company with roots in both Philadelphia and Rehovot, Israel. They utilize functional genomics to create innovative treatments that target rare cancer mutations and improve the lives of patients with limited treatment options. Their lead program focuses on plixorafenib, an investigational, next-generation BRAF inhibitor that effectively inhibits a wide range of BRAF gene alterations in cancer cells. This drug has shown promising clinical safety and efficacy signals in an ongoing Phase 1/2a clinical trial, potentially offering a new treatment pathway for patients with BRAF-mutated cancers.

Fore Biotherapeutics is driven by a patient-first approach and a strong commitment to innovation. Their culture fosters a collaborative, flexible, and fun work environment, attracting top talent in the biotech industry. The company is backed by leading investors with extensive industry knowledge and experience in developing successful oncology companies. They also prioritize strategic partnerships, focusing on in-licensing clinic-ready compounds and accommodating various partnering structures. This allows them to rapidly advance promising treatments for patients with rare cancers and address their unmet medical needs.

Fore Biotherapeutics offers a fully remote work model, providing employees with the flexibility to work from anywhere. This model allows for a greater work-life balance and caters to employees who value flexibility in their work environment. The company emphasizes the importance of creating a culture that is both ambitious and human-focused, promoting the wellbeing and happiness of employees and their families.

Fore Biotherapeutics offers a comprehensive benefits package aimed at supporting employees and their families, encompassing fiscal, physical, and practical aspects. These include competitive salaries, annual and long-term incentive eligibility, 401k with a company match, health and flexible savings accounts, emergency travel and identity theft assistance, multiple medical, dental and vision insurance plans, company-paid life and disability insurance, paid time off, parental leave, volunteer time, a fully remote work model, and an employee assistance program.

Fore Biotherapeutics is a precision oncology company dedicated to developing innovative treatments for patients with rare cancers. They leverage their proprietary functional genomics platform to identify existing compounds with known clinical profiles and a clear path through clinical development. Their mission is to provide "1-to-1" matching between patients and new treatments tailored to them, delivering rapid and high-quality access to the right medicines for the right patients with the hardest-to-treat cancers.

Fore Biotherapeutics promotes a culture that values both its people and its science, striving to create a dynamic and collaborative environment where innovation thrives. The company emphasizes a focus on the well-being and happiness of its employees, fostering a sense of community and teamwork, while also maintaining a strong commitment to its mission of delivering life-saving treatments for cancer patients. This balance between ambition and humanity is reflected in their employee benefits and flexible work arrangements, encouraging a healthy work-life balance and a positive, supportive workplace.

Fore Biotherapeutics is committed to creating a diverse and inclusive workplace where everyone feels valued and respected. They recognize the importance of health disparities and differential access to healthcare in certain populations, and are committed to recruiting and retaining a diverse participant population in their clinical trials. Fore has implemented various strategies to facilitate access to their plixorafenib clinical trials for all eligible participants, ensuring that their research reflects the demographics of cancer patients with BRAF alterations.